ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition

Drug Metabolism and Disposition

Volumn 39, Issue 6, 2011, Pages 1000-1007

  Mason, Cifford W ^a,c   Buhimschi, Irina A ^b   Buhimschi, Catalin S ^b   Dong, Yafeng ^c   Weiner, Carl P ^c   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CYTOKINE RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DRUG TRANSPORT; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LABOR; MICROARRAY ANALYSIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CHORIOAMNIONITIS; FEMALE; HUMANS; LABOR, OBSTETRIC; OBSTETRIC LABOR, PREMATURE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79956124694     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.038166     Document Type: Article

References (44)

1. Bowen RS, Gu Y, Zhang Y, Lewis DF, and Wang Y (2005) Hypoxia promotes interleukin-6 and-8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig 12:428-432. (Pubitemid 41242382)
2. Buhimschi IA, Christner R, and Buhimschi CS (2005) Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 112:173-181. (Pubitemid 40188245)
3. Camus M, Deloménie C, Didier N, Faye A, Gil S, Dauge MC, Mabondzo A, and Farinotti R (2006) Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women. Placenta 27:699-706.
4. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752. (Pubitemid 46856245)
5. Chen YH, Wang JP, Wang H, Sun MF, Wei LZ, Wei W, and Xu DX (2005) Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology 211:242-252. (Pubitemid 40755258)
6. de Vries NA, Zhao J, Kroon E, Buckle T, Beijnen JH, and van Tellingen O (2007) P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin Cancer Res 13:6440-6449. (Pubitemid 350075034)
7. Evseenko DA, Paxton JW, and Keelan JA (2006) ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290:R1357-R1365.
8. Evseenko DA, Paxton JW, and Keelan JA (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 35:595-601. (Pubitemid 46513262)
9. Flad HD, Loppnow H, Rietschel ET, and Ulmer AJ (1993) Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187:303-316. (Pubitemid 23150774)
10. Gil S, Saura R, Forestier F, and Farinotti R (2005) P-glycoprotein expression of the human placenta during pregnancy. Placenta 26:268-270. (Pubitemid 40247016)
11. Holcberg G, Amash A, Sapir O, Sheiner E, Levy S, and Huleihel M (2007) Perfusion with lipopolysaccharide differently affects the secretion of tumor necrosis factor-α and interleukin- 6 by term and preterm human placenta. J Reprod Immunol 74:15-23. (Pubitemid 46679059)
12. Huang da W, Sherman BT, and Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
13. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, and Schinkel AH (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651-1656.
14. Kedziorek DA, Muja N, Walczak P, Ruiz-Cabello J, Gilad AA, Jie CC, and Bulte JW (2010) Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 63:1031-1043.
15. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, and Mitchell MD (1999) Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 181:1530-1536. (Pubitemid 30021903)
16. Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, and Oleszczuk J (2007) Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 20:527-532. (Pubitemid 47221564)
17. -ΔΔCT method. Methods 25:402-408.
18. Llorente L, Richaud-Patin Y, Díaz-Borjón A, Alvarado de la Barrera C, Jakez-Ocampo J, de la Fuente H, Gonzalez-Amaro R, and Diaz-Jouanen E (2000) Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine 67:30-39.
19. Lockwood CJ, Arcuri F, Toti P, Felice CD, Krikun G, Guller S, Buchwalder LF, and Schatz F (2006) Tumor necrosis factor-α and interleukin-1β regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am J Pathol 169:1294-1302. (Pubitemid 351194364)
20. Mason CW, Hassan HE, Kim KP, Cao J, Eddington ND, Newman AH, and Voulalas PJ (2010) Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse. J Pharmacol Exp Ther 333:854-864.
21. Mason CW, Swaan PW, and Weiner CP (2006) Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 194:1513-1523. (Pubitemid 43766889)
22. Mathias AA, Hitti J, and Unadkat JD (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289:R963-R969. (Pubitemid 41397042)
23. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter CA, Völker U, and Kroemer HK (2006) Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 34:524-533.
24. Meyer zu Schwabedissen HE, Jedlitschky G, Gratz M, Haenisch S, Linnemann K, Fusch C, Cascorbi I, and Kroemer HK (2005) Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos 33: 896-904.
25. Nagashige M, Ushigome F, Koyabu N, Hirata K, Kawabuchi M, Hirakawa T, Satoh S, Tsukimori K, Nakano H, Uchiumi T, et al. (2003) Basal membrane localization of MRP1 in human placental trophoblast. Placenta 24:951-958. (Pubitemid 37321810)
26. Nakabayashi M, Sakura M, Takeda Y, and Sato K (1998) Elevated IL-6 in midtrimester amniotic fluid is involved with the onset of preeclampsia. Am J Reprod Immunol 39:329-334. (Pubitemid 28172231)
27. Novotna M, Libra A, Kopecky M, Pavek P, Fendrich Z, Semecky V, and Staud F (2004) P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod Toxicol 18:785-792. (Pubitemid 38987965)
28. Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, and Williamson C (2003) Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C,OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 24:39-44. (Pubitemid 37184694)
29. Petrovic V, Teng S, and Piquette-Miller M (2007) Regulation of drug transporters during infection and inflammation. Mol Interv 7:99-111. (Pubitemid 46683180)
30. Salafia CM, Weigl C, and Silberman L (1989) The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 73:383-389. (Pubitemid 19063617)
31. Shimoya K, Matsuzaki N, Taniguchi T, Kameda T, Koyama M, Neki R, Saji F, and Tanizawa O (1992) Human placenta constitutively produces interleukin-8 during pregnancy and enhances its production in intrauterine infection. Biol Reprod 47:220-226.
32. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
33. St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U, Meier PJ, and Marin JJ (2000) Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279:R1495-R1503.
34. Sukhai M, Yong A, Pak A, and Piquette-MillerM(2001) Decreased expression of P-glycoprotein in interleukin-1β and interleukin-6 treated rat hepatocytes. Inflamm Res 50:362-370. (Pubitemid 32675398)
35. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, and Gibb W (2006) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27:602-609.
36. Teng S and Piquette-Miller M (2008) Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm 5:67-76. (Pubitemid 351300036)
37. Thuerauf N and Fromm MF (2006) The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases. Eur Arch Psychiatry Clin Neurosci 256:281-286. (Pubitemid 44285051)
38. Ueyama J, Nadai M, Kanazawa H, Iwase M, Nakayama H, Hashimoto K, Yokoi T, Baba K, Takagi K, Takagi K, et al. (2005) Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. Eur J Pharmacol 510:127-134. (Pubitemid 40312398)
39. Wang JH, Scollard DA, Teng S, Reilly RM, and Piquette-Miller M (2005) Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging. J Nucl Med 46: 1537-1545. (Pubitemid 46173265)
40. Wang Y, Baier J, Adair CD, Lewis DF, Krueger S, Kruger T, Gurski M, and Brown E (1999) Interleukin-8 stimulates placental prostacyclin production in preeclampsia. Am J Reprod Immunol 42:375-380.
41. Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, and Husslein P (2005) IL-8 concentrations in maternal serum, amniotic fluid and cord blood in relation to different pathogens within the amniotic cavity. J Perinat Med 33:22-26. (Pubitemid 40254812)
42. Yeboah D, Kalabis GM, Sun M, Ou RC, Matthews SG, and Gibb W (2008) Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. Reprod Fertil Dev 20:328-334. (Pubitemid 351156605)
43. Yeboah D, Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, and Gibb W (2006) Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84:1251-1258. (Pubitemid 46707373)
44. Zhang Y, Wang H, Unadkat JD, and Mao Q (2007) Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 35:2154-2158. (Pubitemid 350146200)